A Master Protocol Assessing The Safety, Tolerability, And Efficacy of Anti-Spike (S) SARS-COV-2 Monoclonal Antibodies for the Treatment of Hospitalized Patients with COVID-19
Sponsoring Agencies:
BIOMEDICAL ADVANCED RES & DEVLPMT AUTHOR, REGENERON PHARMACEUTICAL
